Tetsuro Sakai: Clinical Trials

1 trial sponsored by Tetsuro Sakai, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1

Follow Tetsuro Sakai: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pharmacokinetic Study of Sugammadex in Dialysis Patients
Sugammadex - Renal Disease
Phase 1WithdrawnTetsuro Sakai2021-09-102021-09-17

Conditions studied

Kidney Diseases (1)

Interventions

Sugammadex (1)

Countries

United States (1)